| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVLR | Common Stock | Options Exercise | $415K | +30K | +5.18% | $13.84 | 609K | Dec 1, 2021 | Direct | |
| transaction | AVLR | Common Stock | Sale | -$152K | -1.13K | -0.19% | $133.76 | 608K | Dec 1, 2021 | Direct | F1, F2 |
| transaction | AVLR | Common Stock | Sale | -$747K | -5.53K | -0.91% | $134.96 | 603K | Dec 1, 2021 | Direct | F1, F3 |
| transaction | AVLR | Common Stock | Sale | -$611K | -4.5K | -0.75% | $135.67 | 598K | Dec 1, 2021 | Direct | F1, F4 |
| transaction | AVLR | Common Stock | Sale | -$81.9K | -600 | -0.1% | $136.46 | 598K | Dec 1, 2021 | Direct | F1, F5 |
| transaction | AVLR | Common Stock | Sale | -$152K | -1.1K | -0.18% | $138.14 | 597K | Dec 1, 2021 | Direct | F1, F6 |
| transaction | AVLR | Common Stock | Sale | -$1.81M | -13K | -2.18% | $139.42 | 584K | Dec 1, 2021 | Direct | F1, F7 |
| transaction | AVLR | Common Stock | Sale | -$509K | -3.63K | -0.62% | $140.21 | 580K | Dec 1, 2021 | Direct | F1, F8 |
| transaction | AVLR | Common Stock | Sale | -$70.6K | -500 | -0.09% | $141.18 | 579K | Dec 1, 2021 | Direct | F1, F9 |
| holding | AVLR | Common Stock | 109K | Dec 1, 2021 | By McFarlane Family Investments, LLC | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVLR | Stock Option (right to buy) | Options Exercise | $0 | -30K | -100% | $0.00* | 0 | Dec 1, 2021 | Common Stock | 30K | $13.84 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to a Rule 10b5-1 trading plan originally adopted by the Reporting Person on December 9, 2019, and amended on August 11, 2020. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.27 to $134.26, inclusive. Upon request by the Issuer, any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.31 to $135.29, inclusive. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.315 to $136.30, inclusive. |
| F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.38 to $136.70, inclusive. |
| F6 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.86 to $138.80, inclusive. |
| F7 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.91 to $139.88, inclusive. |
| F8 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.97 to $140.83, inclusive. |
| F9 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.03 to $141.65, inclusive. |
| F10 | The Reporting Person disclaims beneficial ownership of the shares of Common Stock held by McFarlane Family Investments, LLC, of which the Reporting Person is the sole manager and a member, except to the extent of his pecuniary interest therein, if any. |
| F11 | 25% of the total shares subject to the option vested and became exercisable on January 1, 2018, and 1/48th of the total shares subject to the option vested and became exercisable monthly thereafter such that the option was fully vested and exercisable on January 1, 2021. |
Chairman and Chief Executive Officer